SCHEMBL6568029

SCHEMBL6568029

COC(=O)c1cc(NC(=O)Nc2ccc(O)c(OC)c2)ccc1OC(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
MAPT P10636 5/20 0.46
RAB9A P51151 2/20 0.43
MAPK1 P28482 2/20 0.43
NPC1 O15118 1/20 0.43
HTT P42858 1/20 0.43
HTR2A P28223 2/20 0.42
HTR2C P28335 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ALDH1A1 P00352 2/20 0.42
EGFR P00533 1/20 0.42
HPGD P15428 1/20 0.42
POLB P06746 1/20 0.42
MCHR1 Q99705 1/20 0.42
MPO P05164 1/20 0.42
LMNA P02545 2/20 0.41
KDM4E B2RXH2 1/20 0.40
GAA P10253 2/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6565825 0.93 KMT2A (0.54) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6567994 0.89 MAPT (0.47) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6565683 0.89 KMT2A (0.50) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6565909 0.88 MEN1 (0.49) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6568077 0.87 KDM4E (0.52) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6565875 0.87 MEN1 (0.47) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6565785 0.86 MEN1 (0.45) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6566524 0.86 MEN1 (0.47) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6565770 0.86 KMT2A (0.45) MEN1KMT2AMAPTRAB9AMAPK1
SCHEMBL6566884 0.86 MEN1 (0.55) MEN1KMT2AMAPTRAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MEN1 4143/4885KMT2A 3137/4885MAPT 4743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.